Stratec SE (LON:0RAR)

Market Cap	278.96M
Revenue (ttm)	225.89M
Net Income (ttm)	12.50M
Shares Out	n/a
EPS (ttm)	1.03
PE Ratio	22.33
Forward PE	16.70
Dividend	0.51 (2.00%)
Ex-Dividend Date	Jun 30, 2025

Volume	45
Average Volume	3,789
Open	25.65
Previous Close	25.65
Day's Range	25.60 - 25.73
52-Week Range	21.80 - 44.40
Beta	0.28
RSI	48.16
Earnings Date	Aug 19, 2025

About Stratec SE

Stratec SE, together with its subsidiaries, provides automation solutions for in-vitro diagnostics and life science companies in Germany, the European Union, and internationally. The company designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers. It also provides consumables for diagnostics and medical applications; and integrating instrumentation and software. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 1979
• Employees: 1,387
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0RAR

Financial Performance

In 2024, Stratec SE's revenue was 257.62 million, a decrease of -4.73% compared to the previous year's 270.41 million. Earnings were 16.02 million, an increase of 4.24%.

Financial numbers in EUR